• Data
    • Overview
    • Clinical notes
    • Images
    • Mother-child
    • Oncology
    • Regulatory grade
    • Truveta Language Model
    • Truveta Live Link
    • Truveta Studio
  • Genomics
  • Solutions
    • Medical devices
    • Life science
    • Public health
    • Healthcare
  • Research
  • Resources
  • About
    • Blog
    • Members
    • Leadership
    • Events & webinars
    • News
    • Careers

Get started
Sign in
Close
Understanding the impact of the COVID-19 pandemic on childhood MMR vaccination patterns

Understanding the impact of the COVID-19 pandemic on childhood MMR vaccination patterns

by Truveta Research | Jun 11, 2025 | Research, Research Insights

Timely receipt of the MMR vaccine for children has been declining since 2021, with just 76.9% of children receiving the MMR vaccine in 2024 on time.  The odds of non-vaccination by age two for measles were higher among male children, children in rural areas, White...
Shifting trends in TKA fixation: Real-world evidence on the changing landscape of cemented vs uncemented TKA

Shifting trends in TKA fixation: Real-world evidence on the changing landscape of cemented vs uncemented TKA

by Truveta Research | Jun 5, 2025 | Research, Research Insights

The percentage of uncemented total knee arthroplasties (TKAs) nearly doubled from 5.7% to 10.3% between 2018 and 2024. Readmission and revision rates were similar between cemented and uncemented TKAs. Cemented TKAs were associated with higher rates of stiffness,...
FDA-approved anti-obesity GLP-1 RA prescription trends among adolescents

FDA-approved anti-obesity GLP-1 RA prescription trends among adolescents

by Truveta Research | Jun 3, 2025 | Research, Research Insights

In collaboration with Reuters, Truveta Research explored trends in FDA-approved anti-obesity GLP-1 RA prescriptions among adolescents. Among the 1,265,399 adolescents (aged 12-17 years) in this study, the average rate of first-time AOM semaglutide prescriptions was...
ASCO 2025: Development and validation of machine learning risk prediction models for detection of early-onset colorectal cancer

ASCO 2025: Development and validation of machine learning risk prediction models for detection of early-onset colorectal cancer

by Truveta staff | May 30, 2025 | Research, Research Insights

Authors: Wilson Lau, PhD ⊕Truveta, Inc, Bellevue, WA,, Youngwon Kim, PhD ⊕Truveta, Inc, Bellevue, WA, Sravanthi Paras, MD ⊕Swedish Medical Center, Seattle, WA, Md Enamul Haque, PhD ⊕Truveta, Inc, Bellevue, WA,, Sara Daraei, PhD ⊕Truveta, Inc, Bellevue, WA, Rajesh Rao,...
ASCO 2025: Changes in colorectal cancer screening and detection following USPSTF expanded recommendations

ASCO 2025: Changes in colorectal cancer screening and detection following USPSTF expanded recommendations

by Truveta Research | May 30, 2025 | Research, Research Insights

Authors: Patricia J. Rodriguez, PhD, MPH ⊕Truveta, Inc, Bellevue, WA Duy Do, PhD ⊕Truveta, Inc, Bellevue, WA, Brianna M. Goodwin Cartwright, MS ⊕Truveta, Inc, Bellevue, WA, Jennifer Liang, MD ⊕Truveta, Inc, Bellevue, WA, Keenan Robbins, MBBS ⊕Washington University...
Prostate cancer is in the headlines — and early detection has never been more important

Prostate cancer is in the headlines — and early detection has never been more important

by Truveta staff | May 29, 2025 | Research

Each year, more than 34,000 men in the U.S. die from prostate cancer. While early-stage disease is often highly treatable, outcomes still vary widely — especially by race, income, and geography. Catching the disease early can save lives, but real-world data on...
« Older Entries
Next Entries »

Share this


Recent posts

  • Real-world evidence on heart failure from GLP-1 and advanced CKD populations
  • Early uptake of oral semaglutide for obesity (Wegovy pill) following FDA approval
  • Use of GLP-1 RAs following label expansion for patients with CVD and overweight or obesity

Follow Truveta


Sign up for our newsletter

Ready to accelerate your research with representative, complete, and timely real-world data?

Truveta Data

Truveta Genome Project

Research

Resources

Blog

News

Careers

Privacy notice

Contact us

© Truveta 2026

Our website uses cookies to ensure you have the best experience.